Literature DB >> 7975740

Antimicrobial susceptibility of Campylobacter fetus subsp. fetus isolated from blood and synovial fluid.

S Y Kwon1, D H Cho, S Y Lee, K Lee, Y Chong.   

Abstract

Campylobacter fetus subsp. fetus is a rare human pathogen, but can cause serious extraintestinal infections. Effective antimicrobial agent is required for the therapy, but we have very limited knowledge on the susceptibility of the organism. In this study, the susceptibility of 25 isolates of the organism to 14 antimicrobial agents was tested by an agar dilution method. Antimicrobial agents with low MIC ranges, in micrograms/ml, were: meropenem < or = 0.25, dirithromycin < or = 0.5, gentamicin < or = 1, amikacin, ofloxacin, tetracycline and erythromycin < or = 2. The MIC range of cefepime was 0.5-8 micrograms/ml, but those of other beta-lactams were relatively high. All of the isolates were interpreted to be susceptible to cefepime, meropenem, amikacin, gentamicin, ofloxacin, tetracycline and dirithromycin. A significant proportion of the isolates were either intermediate or resistant to ampicillin, cephalothin, cefotaxime, aztreonam, loracarbef and erythromycin. In conclusion, the organism remains susceptible to aminoglycosides and tetracycline. Greater in vitro activity of meropenem, ofloxacin and dirithromycin require clinical evaluation.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7975740     DOI: 10.3349/ymj.1994.35.3.314

Source DB:  PubMed          Journal:  Yonsei Med J        ISSN: 0513-5796            Impact factor:   2.759


  5 in total

1.  Epidemiology and antimicrobial susceptibilities of 111 Campylobacter fetus subsp. fetus strains isolated in Québec, Canada, from 1983 to 2000.

Authors:  Carole Tremblay; Christiane Gaudreau; Manon Lorange
Journal:  J Clin Microbiol       Date:  2003-01       Impact factor: 5.948

2.  Antimicrobial susceptibility testing of 59 strains of Campylobacter fetus subsp. fetus.

Authors:  C Tremblay; C Gaudreau
Journal:  Antimicrob Agents Chemother       Date:  1998-07       Impact factor: 5.191

3.  Initial Narrow- or Broad-spectrum Treatment for Meningoencephalitis.

Authors:  Takahiko Fukuchi; Hitoshi Sugawara
Journal:  Intern Med       Date:  2019-09-18       Impact factor: 1.271

Review 4.  Campylobacter Fetus Meningitis in Adults: Report of 2 Cases and Review of the Literature.

Authors:  Anusha van Samkar; Matthijs C Brouwer; Arie van der Ende; Diederik van de Beek
Journal:  Medicine (Baltimore)       Date:  2016-02       Impact factor: 1.889

Review 5.  The Clinical Importance of Campylobacter concisus and Other Human Hosted Campylobacter Species.

Authors:  Fang Liu; Rena Ma; Yiming Wang; Li Zhang
Journal:  Front Cell Infect Microbiol       Date:  2018-07-24       Impact factor: 5.293

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.